These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27868290)

  • 21. Preoperative therapy in locally advanced esophageal cancer.
    Garg PK; Sharma J; Jakhetiya A; Goel A; Gaur MK
    World J Gastroenterol; 2016 Oct; 22(39):8750-8759. PubMed ID: 27818590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
    Levine EA; Farmer MR; Clark P; Mishra G; Ho C; Geisinger KR; Melin SA; Lovato J; Oaks T; Blackstock AW
    Ann Surg; 2006 Apr; 243(4):472-8. PubMed ID: 16552197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concurrent chemoradiotherapy compared with concurrent chemoradiotherapy with surgery in locally advanced resectable esophageal cancer].
    Choi YA; Kim HG; Jung S; Lee DH; Lee JI; Lee JW; Park JY; Shin YW; Kim YS; Kim KH; Yun YH; No JK; Kim CS
    Korean J Gastroenterol; 2009 Jan; 53(1):15-22. PubMed ID: 19158466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.
    Yoo C; Park JH; Yoon DH; Park SI; Kim HR; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Kim YH; Kim SB
    Ann Thorac Surg; 2012 Dec; 94(6):1862-8. PubMed ID: 22959577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer.
    Takebayashi K; Tsubosa Y; Matsuda S; Kawamorita K; Niihara M; Tsushima T; Yokota T; Sato H; Onozawa Y; Ogawa H; Kamijo T; Onitsuka T; Nakagawa M; Yasui H
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27859977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern.
    Versteijne E; van Laarhoven HW; van Hooft JE; van Os RM; Geijsen ED; van Berge Henegouwen MI; Hulshof MC
    Dis Esophagus; 2015 Jul; 28(5):453-9. PubMed ID: 24725186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
    Piessen G; Petyt G; Duhamel A; Mirabel X; Huglo D; Mariette C
    Ann Surg; 2013 Jul; 258(1):66-76. PubMed ID: 23470576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
    Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
    Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study.
    Piessen G; Messager M; Mirabel X; Briez N; Robb WB; Adenis A; Mariette C
    Ann Surg; 2013 Nov; 258(5):793-9; discussion 799-800. PubMed ID: 24096755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
    Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
    Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
    Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant chemoradiotherapy followed by combined thoracoscopic and laparoscopic esophagectomy in the treatment of locally advanced esophageal carcinoma].
    Zhu CC; Chen BF; Kong M; Wang CG; Wang Z; Ma DH; Ye MH; Ye ZR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):943-6. PubMed ID: 22990929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
    Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
    J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
    Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.
    Farinella E; Safar A; Nasser HA; Bouazza F; Liberale G; Paesmans M; Marechal R; Van Laethem JL; Hendlisz A; VanHoutte P; El Nakadi I
    J Surg Oncol; 2016 Dec; 114(7):833-837. PubMed ID: 27778349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.